GlassScriptPhysician profile
Matthew Ballo
NPI 1013017094
$24,706.74
in general payments reported to CMS, 2019-2025
12 companies · $219 in 2025
The $219 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,637 · 2020: $6,766 · 2021: $1,678 · 2022: $648 · 2023: $1,827 · 2024: $5,932 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,800 · Honoraria: $1,500 · Food and Beverage: $1,381 · Travel and Lodging: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,800.00 |
| Honoraria | $1,500.00 |
| Food and Beverage | $1,380.77 |
| Travel and Lodging | $296.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $20,044.56 | 2019-2024 | Optune |
| Elekta, INC. | $1,932.21 | 2019-2024 | Elekta Medical Linear Accelerator |
| Gt Medical Technologies, INC | $1,631.14 | 2022-2023 | Gammatile |
| Zap Surgical Systems, INC. | $437.11 | 2021-2024 | Zap-X Treatment Delivery Software, Zap-X Treatment Planning Software, Zap-X Mv Imager |
| Siemens Medical Solutions USA, INC. | $311.69 | 2022-2025 | Varian Ethos Treatment Planning |
| Medtronic USA, INC. | $151.33 | 2020 | |
| Novartis Pharmaceuticals Corporation | $60.37 | 2021-2022 | |
| Novocure Gmbh | $44.46 | 2025 | Optune Gio |
| Angiodynamics, INC. | $31.84 | 2019 | |
| Daiichi Sankyo INC. | $26.08 | 2019 | |
| Emd Serono, INC. | $22.68 | 2024 | |
| Eisai INC. | $13.27 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Ballo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.